Management

Orchid Chemicals reports Rs 13.2 cr loss

Orchid Chemicals & Pharmaceuticals reported a net loss of Rs 13.20 crore for the quarter ending on September 30, 2009 as compared to Rs 40.66 crore loss last year. - Aurobindo gets nod to market 2 more products in S Africa - Glenmark Pharma Q2 net dips 31% to Rs 81 cr - Natco to make 10 mn strips of generic Tamiflu available by Oct - Orchid gets ANDA"s final nod from USFDA for Zaleplon Capsules - Orchid Pharma settles patent row, stock up 4% - Orchid Pharma settles patent row with Schering-Plough Total income rose to Rs 304.84 crore from Rs 339.14 crore, a drop of 10 per cent, the company said in a filing to the Bombay Stock Exchange (BSE). Shares of the company settled at Rs 153.5, down 3.52 per cent on the BSE today.

Add your comment:

Name:
Site address:	http://
Your message:
Enter today\\\\'s date, 2 digits (spam protection):